During the webinar, Dr. Snežana Jovanović will share her experience with T2 Biosystems sepsis diagnostics. Through case studies, participants will examine the role of early diagnosis of bloodstream ...
Learn from renowned clinical expert, George J. Alangaden, M.D., as he discusses how Henry Ford Health System (HFHS) implemented T2MR and the T2Candida Panel as part of their sepsis protocol for the ...
LEXINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that Expert Review of Medical ...
A new product developed by Lexington-based T2 Biosystems could dramatically improve the survival rate of trauma patients whose bodies are unable to control or stop bleeding. The innovative and ...
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems today announced the completion of a $40 million financing to support the clinical programs and commercialization of T2Candida™, the Company’s flagship ...
Bayer will use T2 Biosystems’ T2 Magnetic Resonance technology platform (T2MR ®) under a multiyear hemostasis research collaboration whose value was not disclosed. The collaboration, disclosed today ...
Lexington, MA, April 24, 2013 (Embargoed until 2:00 PM US Eastern Time) – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the publication ...
T2 Biosystems is powering a highly promising technology (T2MR) that can revolutionize the detection and thereby management of sepsis. Already FDA-approved for various indications, T2MR validated its ...
Data presented at the Innovation Session analyzed the detection time of both T2Bacteria and T2 sepsis panels. High Detection Rate: The T2Bacteria Panel showed broad coverage, detecting 77% of all ...
T2 Biosystems, Inc. has signed a multi-year agreement to provide T2 Biosystems’ T2 Magnetic Resonance technology platform, or T2MR®, for Bayer’s research and development efforts in blood coagulation ...
When infection strikes, the human body strikes back. Yet that reaction often takes a patient down a more perilous path. The body’s severe inflammatory response can lead to sepsis, a potentially ...
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems today announced that it has filed a 510(k) premarket submission for T2Dx and T2Candida with the U.S. Food and Drug Administration (FDA). The premarket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback